P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients
Titel:
P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients
Auteur:
Mazzeschi, M. Sgarzi, M. Romaniello, D. Ambrosi, F. Morselli, A. Girone, C. Pagano, F. Rihawi, K. D'Uva, G. Ferracin, M. Fiorentino, M. Ardizzoni, A. Győrffy, B. Palmer, R. Li, N. Lengner, C. Mossé, Y. Lauriola, M.